Business Development

Histogen has a strong commitment to the development of first in class and best in class product applications within various therapeutic and aesthetic areas. As an innovator and a supplier of unique hypoxic- induced biomaterials, we seek (i) to leverage the Company’s core competencies in order to develop novel products within the field of regenerative medicine, and (ii) to supply partners with our proprietary biomaterials to be incorporated into a broader array of products. In support of this mission, Histogen has made a significant investment in its core team of scientists and engineers, its intellectual property portfolio, and its manufacturing infrastructure.

Histogen’s technology platform produces a multipotent cell conditioned media as well as an extracellular matrix material containing cell-signaling proteins which stimulate stem cells in the body to regenerate tissue. These materials have significant potential in a number of high value aesthetic applications such as hair growth, skin care and soft tissue fillers. In addition, these materials hold promise in therapeutic applications including orthopedics and wound healing. Working closely with industry-leading partners and collaborators, we look to maximize the potential of our proprietary technology platform.

For more information about partnering with Histogen, or to arrange a technology presentation, please contact us at bd@histogeninc.com or 858.526.3100.

Value Drivers

Value Drivers

Histogen is a regenerative medicine company based on the commercialization of products manufactured by hypoxia-induced multipotent stem cells.

Broad range of markets, including products that require no third-party reimbursement, which are underserved and expected to grow

Rich product and patent portfolio

Solutions without the use of embryonic stem cells or animal products